Director dealings: TUI AG's Ebel buys-in
Tui executive Sebastian Ebel purchased 47,580 ordinary shares in the FTSE 100-listed travel outfit on Tuesday.
Cboe DEM 50
19,188.88
15:44 14/11/24
Tui Ag
€7.90
16:30 13/11/24
Ebel, who was appointed to Tui's board following the merger of TUI AG and TUI Travel in December 2014, acquired the shares at an average price of 832.84p each, for a total value of £396,265.
Last month, analysts at AJ Bell pointed out that Tui, among other top-ten rated blue-chip stock recommendations, had actually lost more than the FTSE 100 index had in 2018.
The broker found that the ten FTSE 100 stocks analysts most often rated a ‘buy’ lost an average of 17.3% in 2018, while the index lost 12.5%.
Russ Mould, investment director at AJ Bell, said investment banks and broking firms had failed to identify last year’s winners and losers.
"This is not to gratuitously kick the analysts when they are down. But it does suggest that the real value of broking research lies not with the recommendations but with the industry analysis and distillation of the key company issues that it provides."
As of 1640 GMT, Tui shares had picked up 3.32% to 853.40p.
Top Director Buys
TUI AG Reg Shs (DI) (TUI)
Director name: Mr Sebastian Ebel
Amount purchased: 47,580 @ 832.84p
Value: £396,265
Xtract Resources (XTR)
Director name: Mr Colin Bird
Amount purchased: 4,614,035 @ 2.85p
Value: £131,500
Grit Real Estate Income Group Limited NPV (DI) (GR1T)
Director name: Ms Bronwyn Corbett
Amount purchased: 10,000 @ $2.37
Value: $23,715
Draper Esprit (GROW)
Director name: Mr Benjamin David Wilkinson
Amount purchased: 3,125 @ 480.00p
Value: £15,000
Top Director Sells
WH Smith (SMWH)
Director name: Mr Robert Moorhead
Amount sold: 25,000 @ 2,037.79p
Value: £509,448
WH Smith (SMWH)
Director name: Mr Robert Moorhead
Amount sold: 25,000 @ 2,037.79p
Value: £509,448
GlaxoSmithKline (GSK)
Director name: Mr Simon Dingemans
Amount sold: 20,263 @ 1,571.60p
Value: £318,453
GlaxoSmithKline (GSK)
Director name: Ms Emma Walmsley
Amount sold: 15,345 @ 1,575.60p
Value: £241,776
GlaxoSmithKline (GSK)
Director name: Mr Simon Dingemans
Amount sold: 11,955 @ 1,571.60p
Value: £187,885
GlaxoSmithKline (GSK)
Director name: Ms Emma Walmsley
Amount sold: 9,053 @ 1,575.60p
Value: £142,639